Literature DB >> 14579161

Expression of NKB1 on peripheral T cells in patients with rheumatoid arthritis.

Y Nakiri1, H Kaneko, S Morimoto, J Suzuki, Y Tokano, H Hashimoto.   

Abstract

NKB1 inhibits cytoxic activity of T lymphocytes mediated by superantigens, which is one of the contributing factors in the pathogenesis of rheumatoid arthritis (RA). In this study, we determined the expression of NKB1 on peripheral blood T cells in patients with RA. Our findings revealed that among patients with RA, NKB1(+) CD8(+ )T cells decreased significantly in comparison to controls (ratio: P < 0.05; absolute number: P < 0.005), and this decrease was not related to or influenced by HLA-Bw4 as a ligand of NKB1. This result may suggest that decreased expression of NKB1(+) CD8(+ )T cells contributes to the pathogenesis of RA mediated by the activation of CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14579161     DOI: 10.1007/s10067-003-0737-y

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  2 in total

1.  Expression of CD22 on peripheral B cells in patients with rheumatoid arthritis: relation to CD5-positive B cells.

Authors:  Yutaka Nakiri; Kentarou Minowa; Jun Suzuki; Akiko Mitsuo; Hirofumi Amano; Shinji Morimoto; Yoshiaki Tokano; Yoshinari Takasaki
Journal:  Clin Rheumatol       Date:  2007-06-22       Impact factor: 2.980

2.  No correlation exists between disease activity and the expression of killer-cell immunoglobulin-like receptors in patients with rheumatoid arthritis.

Authors:  Toshiaki Kogure; Takeshi Tatsumi; Atsushi Niizawa; Hiroshi Fujinaga; Tomoyuki Ito; Yutaka Shimada; Katsutoshi Terasawa
Journal:  Mediators Inflamm       Date:  2006-12-27       Impact factor: 4.711

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.